News

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...
President Donald Trump is expected to sign an executive order allowing for the inclusion of private market investments in ...
Zacks Small Cap Research on MSN20m

LGVN Continues to Expand Heart Treatment Options

LGVN READ THE FULL LGVN RESEARCH REPORT Longeveron (NASDAQ:LGVN) is a company that should be getting more attention from investors for the treatments that could be coming to market in the near future.